The Medicines Company: J.P. Morgan Healthcare Conference (The Medicines Company) - Jan 9, 2013 - Anticipated launch in US for dyslipidemia in 2017 or beyond; Anticipated launch in Europe and Middle East for dyslipidemia in 2017 or beyond; Anticipated launch in Asia / Pacific region for dyslipidemia in 2017 or beyond
Anticipated launch Europe • Anticipated launch non-US • Anticipated launch US • Dyslipidemia
|